...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues
【24h】

Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues

机译:加州鱼雷乙酰胆碱酯酶与两个类似多奈哌齐的刚性类似物相互作用的动力学和结构研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract Acetylcholinesterase inhibitors were introduced for the symptomatic treatment of Alzheimer’s disease (AD). Among the currently approved inhibitors, donepezil (DNP) is one of the most preferred choices in AD therapy. The X-ray crystal structures of Torpedo californica AChE in complex with two novel rigid DNP-like analogs, compounds 1 and 2 , have been determined. Kinetic studies indicated that compounds 1 and 2 show a mixed-type inhibition against TcAChE, with Ki values of 11.12?±?2.88 and 29.86?±?1.12?nM, respectively. The DNP rigidification results in a likely entropy-enthalpy compensation with solvation effects contributing primarily to AChE binding affinity. Molecular docking evidenced the molecular basis for the binding of compounds 1 and 2 to the active site of β-secretase-1. Overall, these simplified DNP derivatives may represent new structural templates for the design of lead compounds for a more effective therapeutic strategy against AD by foreseeing a dual AChE and BACE-1 inhibitory activity.
机译:摘要乙酰胆碱酯酶抑制剂被引入对症治疗阿尔茨海默氏病(AD)。在目前批准的抑制剂中,多奈哌齐(DNP)是AD治疗中最优选的选择之一。已经确定了与两种新型刚性DNP类类似物化合物1和2配合使用的加州鱼雷AChE的X射线晶体结构。动力学研究表明,化合物1和2对TcAChE表现出混合型抑制作用,K i值分别为11.12?±?2.88和29.86?±?1.12?nM。 DNP硬化导致可能产生的熵焓补偿,而溶剂化效应主要有助于AChE结合亲和力。分子对接证明了化合物1和2与β-分泌酶-1活性位点结合的分子基础。总体而言,这些简化的DNP衍生物可能代表用于设计先导化合物的新结构模板,从而通过预见AChE和BACE-1的双重抑制活性而更有效地治疗AD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号